Cargando…

Targeting Natural Killer T Cells in Solid Malignancies

Natural killer T (NKT) cells are a unique subset of lymphocytes that recognize lipid antigens in the context of the non-classical class I MHC molecule, CD1d, and serve as a link between the innate and adaptive immune system through their expeditious release of cytokines. Whereas NKT have well-establ...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ingram, Zewde, Madan, Shriya, Merchant, Jenoy, Carter, Zakiya, Gordon, Zen, Carey, Gregory, Webb, Tonya J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8227159/ https://www.ncbi.nlm.nih.gov/pubmed/34072042 http://dx.doi.org/10.3390/cells10061329

Ejemplares similares

Current Developments in the Preclinical and Clinical use of Natural Killer T cells
por: Kratzmeier, Christina, et al.
Publicado: (2022)

Sphingosine Kinase Blockade Leads to Increased Natural Killer T Cell Responses to Mantle Cell Lymphoma
por: Lee, Michael S., et al.
Publicado: (2020)

Mixed Signals: Co-Stimulation in Invariant Natural Killer T Cell-Mediated Cancer Immunotherapy
por: Shissler, Susannah C., et al.
Publicado: (2017)

Artificial Antigen Presenting Cell (aAPC) Mediated Activation and Expansion of Natural Killer T Cells
por: East, James E., et al.
Publicado: (2012)

Natural Killer Cells Modulation in Hematological Malignancies
por: Baier, Céline, et al.
Publicado: (2013)

Natural killer cells in non-hematopoietic malignancies
por: Desbois, Mélanie, et al.
Publicado: (2012)

Natural Killer T and Natural Killer Cell-Based Immunotherapy Strategies Targeting Cancer
por: Iyoda, Tomonori, et al.
Publicado: (2023)

Role of Natural Killer Cells in HIV-Associated Malignancies
por: Leal, Fabio E., et al.
Publicado: (2017)

Natural Killer Cells in the Malignant Niche of Multiple Myeloma
por: Venglar, Ondrej, et al.
Publicado: (2022)

Natural killer-mediated lysis of normal and malignant target cells, and its regulation by monocytes
Publicado: (1985)

Targeting immune checkpoints: how to use natural killer cells for fighting against solid tumors
por: Ghaedrahmati, Farhoodeh, et al.
Publicado: (2022)

Revving up Natural Killer Cells and Cytokine-Induced Killer Cells Against Hematological Malignancies
por: Pittari, Gianfranco, et al.
Publicado: (2015)

Therapeutic Potential and Challenges of Natural Killer Cells in Treatment of Solid Tumors
por: Gras Navarro, Andrea, et al.
Publicado: (2015)

Treatment of solid tumor with autologous natural killer cells in mouse models
por: Liao, Nan-Shih
Publicado: (2014)

Overcoming Resistance to Natural Killer Cell Based Immunotherapies for Solid Tumors
por: Nayyar, Gaurav, et al.
Publicado: (2019)

Natural Killer Cell-Mediated Cellular Therapy of Hematological Malignancies
por: Sahin, Ugur, et al.
Publicado: (2019)

Recent Advances in the Diagnosis and Treatment of Natural Killer Cell Malignancies
por: Tse, Eric, et al.
Publicado: (2022)

Modeling Natural Killer Cell Targeted Immunotherapies
por: Lopez-Lastra, Silvia, et al.
Publicado: (2017)

Targeting Natural Killer Cells for Tumor Immunotherapy
por: Zhang, Cai, et al.
Publicado: (2020)

Patient’s Natural Killer Cells in the Era of Targeted Therapies: Role for Tumor Killers
por: Messaoudene, Meriem, et al.
Publicado: (2017)

Natural killer cells and natural killer T cells in Lyme arthritis
por: Katchar, Kia, et al.
Publicado: (2013)

Strategies to Augment Natural Killer (NK) Cell Activity against Solid Tumors
por: Chen, Ziqing, et al.
Publicado: (2019)

Natural Killer Cell Therapy: A New Treatment Paradigm for Solid Tumors
por: Oh, Sooyeon, et al.
Publicado: (2019)

Approaches to Enhance Natural Killer Cell-Based Immunotherapy for Pediatric Solid Tumors
por: Quamine, Aicha E., et al.
Publicado: (2021)

Effector Functions of Natural Killer Cell Subsets in the Control of Hematological Malignancies
por: Gismondi, Angela, et al.
Publicado: (2015)

Natural Killer Cell-Based Immunotherapy in Gynecologic Malignancy: A Review
por: Uppendahl, Locke D., et al.
Publicado: (2018)

Natural killer cell therapy for hematologic malignancies: successes, challenges, and the future
por: Lamb, Margaret G., et al.
Publicado: (2021)

Evaluation of tumor response to cytokine-induced killer cells therapy in malignant solid tumors
por: Li, Xiao-Dong, et al.
Publicado: (2014)

Roles of Natural Killer T Cells and Natural Killer Cells in Kidney Injury
por: Uchida, Takahiro, et al.
Publicado: (2019)

Pharmacological targeting of natural killer cells for cancer immunotherapy
por: Miyazato, Kiho, et al.
Publicado: (2020)

Trispecific natural killer cell nanoengagers for targeted chemoimmunotherapy
por: Au, Kin Man, et al.
Publicado: (2020)

Updating targets for natural killer/T-cell lymphoma immunotherapy
por: Xue, Weili, et al.
Publicado: (2021)

Enhancing Natural Killer Cell Targeting of Pediatric Sarcoma
por: Omer, Natacha, et al.
Publicado: (2021)

Novel Application of Radotinib for the Treatment of Solid Tumors via Natural Killer Cell Activation
por: Kim, Kyung Eun, et al.
Publicado: (2018)

Antitumor Immunity Exerted by Natural Killer and Natural Killer T Cells in the Liver
por: Nakashima, Hiroyuki, et al.
Publicado: (2023)

Natural Killers Are Made Not Born: How to Exploit NK Cells in Lung Malignancies
por: Carrega, Paolo, et al.
Publicado: (2017)

Natural killer T cells
por: Kanellopoulos, Jean
Publicado: (2015)

Infections, Reactions of Natural Killer T Cells and Natural Killer Cells, and Kidney Injury
por: Uchida, Takahiro, et al.
Publicado: (2022)

Natural killer T (NKT) cells accelerate Shiga toxin type 2 (Stx2) pathology in mice
por: Obata, Fumiko, et al.
Publicado: (2015)

Targeting human leukocyte antigen G with chimeric antigen receptors of natural killer cells convert immunosuppression to ablate solid tumors
por: Jan, Chia-Ing, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_apj6hm6q3fgfmsma87f18203c5